Biomarkers in heart failure management.

Biomarkers in heart failure management. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Biomarkers in heart failure management. Abstract Text:

Debra L Isaac,

PURPOSE OF REVIEW: Recent literature on the role of biomarkers in heart failure is reviewed, focusing on B-type natriuretic peptide. RECENT FINDINGS: Knowledge of the processes which increase ventricular stress, thus increasing B-type natriuretic peptide, is key to appropriate utilization and interpretation of B-type natriuretic peptide levels. B-type natriuretic peptide is a useful adjunct to confirm or rule out heart failure. B-type natriuretic peptide is a robust prognostic indicator in all stages of heart failure, with prognostic significance in patients undergoing cardiac and noncardiac surgery, and in those with acute coronary syndromes. Serial B-type natriuretic peptide testing predicts outcomes in hospitalized patients with heart failure. The role of B-type natriuretic peptide in screening high-risk populations is promising, but its use in unselected populations is unclear. There is increasing evidence that the use of B-type natriuretic peptide to guide heart failure management is associated with improved clinical outcomes and reduced health costs. SUMMARY: Biomarkers play an important role in heart failure, but there remain unanswered questions regarding optimization of their use. They should be used as an adjunct to, not replacement for, clinical assessment. Currently available B-type natriuretic peptide assays have limitations relating to clinical variability and assay specificity. Other neurohormonal, inflammatory and metabolic markers may add complementary information to that provided by currently available B-type natriuretic peptide assays.

Biomarkers in heart failure management. Publishing Authors By Initials

DL Isaac,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Biomarkers in heart failure management. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current opinion in cardiology

VOLUME: 23

Page Numbers: 127-33

Journal Abbreviation: Curr. Opin. Cardiol.

ISSN: 0268-4705

DAY: 27

MONTH: Mar

YEAR: 2008

Biomarkers in heart failure management. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8608087

Biomarkers in heart failure management. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Biomarkers in heart failure management. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Biomarkers in heart failure management.

AFFILIATION: Foothills Medical Centre/University of Calgary, Calgary, Alberta, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Opin Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Biomarkers in heart failure management Related Publications

• ACUTE PANCREATITIS.
• An essential role for PICK1 in NMDA receptor-dependent bidirectional synaptic plasticity.
• Bioinformatic analysis of the neprilysin (M13) family of peptidases reveals complex evolutionary and functional relationships.
• Biomarkers in heart failure management.
• DARK PIGMENT FORMATION IN VERTICILLIUM ALBO-ATRUM.
• Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects.
• Electrophysiological recordings from neonatal neocortical brain slices.
• End-of-Life Care for the Hospitalized Patient.
• Energy requirements and physical achievements according to body composition of young soldiers offered food to satiety.
• Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers.
• External wear of the polyethylene socket in cemented total hip arthroplasty.
• Genetic analysis of complement C1s deficiency associated with systemic lupus erythematosus highlights alternative splicing of normal C1s gene.
• Helicobacter pylori infection rates at a family practice in Pohnpei, Federated States of Micronesia.
• Human bone microstructure studied by collagenase etching.
• Impaired dendritic cell differentiation and maturation in the absence of C3.
• Male accessory glands of Drosophila melanogaster make a secreted angiotensin I-converting enzyme (ANCE), suggesting a role for the peptide-processing enzyme in seminal fluid.
• Megestrol acetate treatment of failure to thrive in congenital heart disease.
• Muscular development as a factor in body composition.
• Notalgia paresthetica - a case report.
• Pair bonding in the wild mouse Mus spretus: inference on the mating system.
• Parenting children under three years of age in a south Indian setting.
• Physiological and biochemical evaluation of potential antifatigue drugs. I. The effects of aspartic acid salts (Mg and K) on the performance of men.
• Source monitoring in alcoholism.
• Suggestions for organizing a quality assurance program.
• The D144E Substitution in the VSX1 Gene: A Non-pathogenic Variant or a Disease Causing Mutation?
• The effects of light reinforcement and noise on young and old squirrel monkeys (Saimiri sciureus).
• The lateral atlanto-axial joint as a source of headache in congenital atlanto-occipital fusion.
• The need for a national emergency health services database.
• [Injectable formulation of Rofenid. Clinical efficience of a new parenteral therapy in reumatology (author's transl)]
• [Verification of the Mismatch Negativity (MMN) responses in normal adult subjects.]